148 related articles for article (PubMed ID: 7937720)
41. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases.
Sato O; Wada T; Kawai A; Yamaguchi U; Makimoto A; Kokai Y; Yamashita T; Chuman H; Beppu Y; Tani Y; Hasegawa T
Cancer; 2005 May; 103(9):1881-90. PubMed ID: 15772959
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung.
Tateishi M; Ishida T; Mitsudomi T; Kaneko S; Sugimachi K
Cancer Res; 1990 Nov; 50(21):7077-80. PubMed ID: 2208175
[TBL] [Abstract][Full Text] [Related]
43. Activated Akt expression has significant correlation with EGFR and TGF-alpha expressions in stage I NSCLC.
Mukohara T; Kudoh S; Matsuura K; Yamauchi S; Kimura T; Yoshimura N; Kanazawa H; Hirata K; Inoue K; Wanibuchi H; Fukushima S; Yoshikawa J
Anticancer Res; 2004; 24(1):11-7. PubMed ID: 15015570
[TBL] [Abstract][Full Text] [Related]
44. Expression of growth factor and epidermal growth factor receptor encoded transcripts in human gastric tissues.
Bennett C; Paterson IM; Corbishley CM; Luqmani YA
Cancer Res; 1989 Apr; 49(8):2104-11. PubMed ID: 2702651
[TBL] [Abstract][Full Text] [Related]
45. Coexpression of transforming growth factor-alpha and épidermal growth factor receptor in capillary hemangioblastomas of the central nervous system.
Reifenberger G; Reifenberger J; Bilzer T; Wechsler W; Collins VP
Am J Pathol; 1995 Aug; 147(2):245-50. PubMed ID: 7639324
[TBL] [Abstract][Full Text] [Related]
46. Amplification of epidermal growth factor receptor gene in renal cell carcinoma.
El-Hariry I; Powles T; Lau MR; Sternberg CN; Ravaud A; von der Maase H; Zantl N; Harper P; Rolland F; Audhuy B; Barthel F; Machiels JP; Patel P; Kreuser ED; Hawkins RE
Eur J Cancer; 2010 Mar; 46(5):859-62. PubMed ID: 20167476
[TBL] [Abstract][Full Text] [Related]
47. The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trial.
Schober R; Bilzer T; Waha A; Reifenberger G; Wechsler W; von Deimling A; Wiestler OD; Westphal M; Kemshead JT; Vega F
Clin Neuropathol; 1995; 14(3):169-74. PubMed ID: 7671460
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical detection of the epidermal growth factor receptor in paraffin-embedded human tissues.
Gullick WJ; Hughes CM; Mellon K; Neal DE; Lemoine NR
J Pathol; 1991 Aug; 164(4):285-9. PubMed ID: 1681040
[TBL] [Abstract][Full Text] [Related]
49. Apoptosis and growth factors in parathyroid adenomas.
Kvasnicka T; Wang W; Johansson H; Sandelin K; Grimelius L
Horm Metab Res; 1997 Nov; 29(11):544-8. PubMed ID: 9479553
[TBL] [Abstract][Full Text] [Related]
50. The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation.
Cohen D; Lane B; Jin T; Magi-Galluzzi C; Finke J; Rini BI; Bukowski RM; Zhou M
Clin Genitourin Cancer; 2007 Mar; 5(4):264-70. PubMed ID: 17553206
[TBL] [Abstract][Full Text] [Related]
51. A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease.
Cozzolino M; Lu Y; Sato T; Yang J; Suarez IG; Brancaccio D; Slatopolsky E; Dusso AS
Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1096-102. PubMed ID: 15998841
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of cathepsin D and epidermal growth factor receptor in prostate carcinoma.
Maygarden SJ; Novotny DB; Moul JW; Bae VL; Ware JL
Mod Pathol; 1994 Dec; 7(9):930-6. PubMed ID: 7892162
[TBL] [Abstract][Full Text] [Related]
53. Epidermal growth factor receptor expression in pancreatic carcinoma using tissue microarray technique.
Bloomston M; Bhardwaj A; Ellison EC; Frankel WL
Dig Surg; 2006; 23(1-2):74-9. PubMed ID: 16717472
[TBL] [Abstract][Full Text] [Related]
54. Quantitative analysis of the expression of TGF-alpha and EGFR in papillary thyroid carcinoma: clinicopathological relevance.
Lam AK; Lau KK; Gopalan V; Luk J; Lo CY
Pathology; 2011 Jan; 43(1):40-7. PubMed ID: 21240064
[TBL] [Abstract][Full Text] [Related]
55. Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice.
Moore AB; He H; Yoshida A; Rico PJ; Haseman JK; Dixon D
Exp Toxicol Pathol; 2000 Jun; 52(3):195-200. PubMed ID: 10930119
[TBL] [Abstract][Full Text] [Related]
56. Expression of epidermal growth factor receptor (EGFr) immunoreactivity in human cutaneous nerves and sensory corpuscles.
Vega JA; Vazquez E; Naves FJ; Calzada B; del Valle ME; Represa JJ
Anat Rec; 1994 Sep; 240(1):125-30. PubMed ID: 7810909
[TBL] [Abstract][Full Text] [Related]
57. [Characterization of renal cell carcinoma: current topics].
Kotake T; Kinouchi T
Gan To Kagaku Ryoho; 1994 Jan; 21(1):5-11. PubMed ID: 7507313
[TBL] [Abstract][Full Text] [Related]
58. Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas.
Waha A; Baumann A; Wolf HK; Fimmers R; Neumann J; Kindermann D; Astrahantseff K; Blümcke I; von Deimling A; Schlegel U
J Neurosurg; 1996 Oct; 85(4):634-41. PubMed ID: 8814167
[TBL] [Abstract][Full Text] [Related]
59. Somatostatin receptors in human renal cell carcinomas.
Reubi JC; Kvols L
Cancer Res; 1992 Nov; 52(21):6074-8. PubMed ID: 1394233
[TBL] [Abstract][Full Text] [Related]
60. Epidermal growth factor receptors in colorectal carcinoma.
Moorghen M; Ince P; Finney KJ; Watson AJ; Harris AL
Anticancer Res; 1990; 10(3):605-11. PubMed ID: 2195985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
